Dolby Laboratories, Inc.
DLB
$75.75
-$0.04-0.05%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | 39.52% | 30.48% | -3.09% | -21.46% | 2.62% |
| Total Depreciation and Amortization | -2.71% | -8.57% | -7.06% | -6.69% | -4.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.66% | -24.98% | 16.15% | 62.43% | 44.66% |
| Change in Net Operating Assets | 77.93% | -153.82% | -52.88% | 64.22% | -313.94% |
| Cash from Operations | 33.38% | -10.85% | -11.18% | 2.89% | -7.05% |
| Capital Expenditure | -5.02% | 1.09% | 6.24% | 16.39% | 28.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -2,003.43% | -1,998.13% | -100.00% | 44,992.98% | 167.34% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 648.11% | 293.58% | -134.40% | -125.30% | 147.97% |
| Cash from Investing | -1,211.82% | -628.16% | -234.64% | -596.84% | 118.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.11% | -14.35% | 22.37% | 27.78% | 17.75% |
| Repurchase of Common Stock | 40.18% | -10.34% | 45.39% | 63.80% | 61.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.83% | -10.80% | -9.78% | -7.72% | -5.40% |
| Other Financing Activities | -1,311.37% | -1,869.19% | -488.38% | -36.68% | -36.68% |
| Cash from Financing | 18.99% | -21.54% | 38.02% | 58.34% | 56.70% |
| Foreign Exchange rate Adjustments | -314.68% | 29.69% | -181.39% | 79.58% | 149.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.68% | -226.70% | 69.84% | 160.78% | 117.83% |